These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 11920732

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
    Edwards J, Duncan P, Going JJ, Grigor KM, Watters AD, Bartlett JM.
    Br J Cancer; 2001 Dec 14; 85(12):1894-9. PubMed ID: 11747332
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bladder neoplasms--regions at chromosome 9 with putative tumour suppressor genes.
    Wada T, Berggren P, Steineck G, Adolfsson J, Wijkström H, Norming U, Hansson J, Hemminki K, Larsson P.
    Scand J Urol Nephrol; 2003 Dec 14; 37(2):106-11. PubMed ID: 12745717
    [Abstract] [Full Text] [Related]

  • 8. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.
    Bartoletti R, Cai T, Nesi G, Roberta Girardi L, Baroni G, Dal Canto M.
    J Surg Res; 2007 Dec 14; 143(2):422-7. PubMed ID: 17612565
    [Abstract] [Full Text] [Related]

  • 9. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.
    Nishiyama H, Takahashi T, Kakehi Y, Habuchi T, Knowles MA.
    Genes Chromosomes Cancer; 1999 Oct 14; 26(2):171-5. PubMed ID: 10469456
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci.
    Habuchi T, Devlin J, Elder PA, Knowles MA.
    Oncogene; 1995 Oct 19; 11(8):1671-4. PubMed ID: 7478593
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The random development of LOH on chromosome 9q in superficial bladder cancers.
    van Tilborg AA, de Vries A, de Bont M, Groenfeld LE, Zwarthoff EC.
    J Pathol; 2002 Nov 19; 198(3):352-8. PubMed ID: 12375268
    [Abstract] [Full Text] [Related]

  • 14. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
    Czerniak B, Chaturvedi V, Li L, Hodges S, Johnston D, Roy JY, Luthra R, Logothetis C, Von Eschenbach AC, Grossman HB, Benedict WF, Batsakis JG.
    Oncogene; 1999 Feb 04; 18(5):1185-96. PubMed ID: 10022124
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Loss of chromosome 9 in tissue sections of transitional cell carcinomas as detected by interphase cytogenetics. A comparison with RFLP analysis.
    Poddighe PJ, Bringuier PP, Vallinga M, Schalken JA, Ramaekers FC, Hopman AH.
    J Pathol; 1996 Jun 04; 179(2):169-76. PubMed ID: 8758209
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD, Carr MD, Eble JN, Wang M, Lopez-Beltran A, Cheng L.
    Cancer; 2005 Nov 01; 104(9):1901-10. PubMed ID: 16196038
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.